Page 112 - MemoriaCIBER2019-ENG

112
CIBER Annual report 2019
Patents owned by CIBER
Patents granted
• Inactivated mycobacteria for oral use in the prevention of tuberculosis.
Patent pre-grants
• Method for predicting response to continuous positive air pressure treatment. Patents applied for
PCT:
• Method and apparatus for the cardiovascular assessment of a subject in need thereof.
• In vitro method for the diagnosis or detection of non-tuberculous mycobacteria.
• Identification of metabolomic signatures in urine samples for tuberculosis diagnosis.
National Phases:
• In vitro method to identify severity stages in patients with bronchial asthma.
Clinical Guides
• Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Gra- ding of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence.
• Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases.
• ARIA masterclass 2018: From guidelines to real-life implementation.
• 2019 ARIA Care pathways for allergen immunotherapy.
• Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rinitis and asthma.
• EPOS2020: development strategy and goals for the latest European Position Paper on Rhinosinusitis.
• Dilemmas and New Paradigms in Asthma Management.
• Practical Guide to the Identification and Diagnosis of Asthma-COPD Overlap (ACO).
• Patients with Chronic Obstructive Pulmonary Disease Exacerbations: Recommendations for Diagnosis, Treat- ment and Care.
• Evaluation and Management of Obesity Hypoventilation Syndrome. An Official American Thoracic Society Clini- cal Practice Guideline.